Clinical Trial

Detecting Colorectal Cancer With Liver Metastatic Lesions Using Novel Precise Imaging Tools

Study acronym: PSMA
Completed Phase 1
View on ClinicalTrials.gov →
Summary
This study will demonstrate the diagnostic utility of PSMA PET among patients with CRC with liver metastasis.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-11; most recent amendment 2026-07-01.
Status change: Not Yet Recruiting → Completed 2026-07-01
Trial Details
NCT Number NCT06935149
Lead Sponsor Primo Biotechnology Co., Ltd
Collaborators: Kaoshiung Chang Gung Memorial Hospital
Conditions Liver Metastasis Colon Cancer
Enrollment 5 participants
Start Date 2025-10-31
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-06